- Singapore’s Ignition AI Accelerator partners Pfizer
- Collaboration aims to advance biopharma AI
- Partnership leverages Singapore’s tech ecosystem to accelerate drug discovery
AI Meets Pharmaceuticals
Ignition AI Accelerator, a collaboration between NVIDIA, Tribe, and Digital Industry Singapore (DISG), has partnered Pfizer to advance the biopharma sector through artificial intelligence. This alliance aims to accelerate drug discovery and research processes.
Singapore’s Tech Ecosystem Boost
The partnership leverages Ignition AI Accelerator’s extensive Southeast Asian network, including media, government, universities, and investors. It aligns Singapore’s $25 billion investment in science and technology research under the RIE 2025 plan.
Global Innovation Hub
This collaboration positions Ignition AI Accelerator at the intersection of AI and healthcare. It empowers local ecosystem partners and biomedical startups, fostering the development of groundbreaking therapies and advancing precision medicine globally.
